Doxorubicin

SAN DIEGO — Paolo Caimi, MD, spoke with Healio about the latest results from the POLARIX trial presented at ASH Annual Meeting and Exposition.

In this video, Tycel Phillips, MD, discusses challenges in diagnosing DLBCL.

Women who received anthracycline chemotherapy following a childhood cancer diagnosis are at an increased risk for subsequent breast cancer later in life, according to data published in Nature Medicine.

Pediatric-inspired protocols and hyper-CVAD conferred comparable survival for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia, according to study results.

Patients with muscle-invasive bladder cancer receiving dose-dense methotrexate, vinblastine, doxorubicin and cisplatinhad improved OS at 5 years compared with gemcitabine and cisplatin, according to a presentation at ASCO Annual Meeting.

NEW ORLEANS — Health-related quality of life in patients with diffuse large B-cell lymphoma improved in a comparison of two therapy regimens.

Doxorubicin in combination with trabectedin appeared to be an effective and safe first-line therapy for metastatic leiomyosarcoma, according to results of the phase 2 LMS-02 study presented during the ASCO20 Virtual Scientific Program.

The FDA’s Oncologic Drugs Advisory Committee, or ODAC, today voted 11-0 in favor of approval of tazemetostat for the treatment of adults with metastatic or locally advanced epithelioid sarcoma who are not eligible for curative surgery.